Roche blood test could help 'personalize' cancer immunotherapy

MADRID (Reuters) - A new blood test from Roche and Foundation Medicine has shown it can accurately measure the number of mutations within a tumor, potentially helping doctors predict which patients may respond best to some immunotherapies.